| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 20611 |
|
41,726 |
18,343 |
$993K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,185 |
21,804 |
$582K |
| 64483 |
|
3,629 |
3,519 |
$216K |
| 64493 |
|
3,094 |
2,904 |
$139K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
8,915 |
3,463 |
$135K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,947 |
2,944 |
$129K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,239 |
3,902 |
$127K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,587 |
970 |
$116K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,278 |
1,299 |
$102K |
| 64484 |
|
3,620 |
3,511 |
$98K |
| 62323 |
|
1,518 |
1,504 |
$96K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
4,314 |
1,847 |
$94K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,193 |
1,279 |
$85K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,139 |
2,134 |
$68K |
| 64494 |
|
3,087 |
2,897 |
$67K |
| 64490 |
|
1,181 |
1,125 |
$62K |
| 27096 |
|
1,324 |
1,269 |
$53K |
| 64479 |
|
594 |
585 |
$37K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
1,626 |
734 |
$35K |
| 97161 |
|
363 |
358 |
$31K |
| 64491 |
|
1,178 |
1,122 |
$28K |
| 64418 |
|
1,251 |
1,223 |
$28K |
| 64495 |
|
1,306 |
1,198 |
$22K |
| 64454 |
|
429 |
407 |
$20K |
| 64480 |
|
594 |
585 |
$19K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
16,630 |
14,166 |
$18K |
| 77002 |
|
858 |
811 |
$16K |
| 95886 |
|
364 |
364 |
$15K |
| 97162 |
|
179 |
179 |
$15K |
| 95911 |
|
258 |
258 |
$13K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
5,188 |
5,018 |
$12K |
| 97164 |
|
240 |
223 |
$12K |
| 64635 |
|
95 |
93 |
$8K |
| 64492 |
|
334 |
318 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
467 |
454 |
$7K |
| 64640 |
|
100 |
100 |
$6K |
| 64636 |
|
94 |
92 |
$4K |
| 95923 |
|
106 |
106 |
$3K |
| 64450 |
|
108 |
102 |
$2K |
| 95913 |
|
41 |
41 |
$2K |
| 95912 |
|
12 |
12 |
$670.10 |
| 99442 |
|
22 |
19 |
$555.46 |
| 76942 |
|
16 |
16 |
$211.09 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,733 |
1,725 |
$103.22 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,750 |
1,464 |
$11.70 |
| G9275 |
Documentation that patient is a current non-tobacco user |
901 |
896 |
$5.40 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
962 |
775 |
$2.25 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,253 |
1,003 |
$2.25 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
47 |
46 |
$0.45 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
140 |
136 |
$0.45 |
| 3725F |
|
1,503 |
1,495 |
$0.00 |
| 3288F |
|
1,658 |
1,650 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
312 |
310 |
$0.00 |
| 3077F |
|
383 |
341 |
$0.00 |
| 3078F |
|
858 |
701 |
$0.00 |
| 1100F |
|
12 |
12 |
$0.00 |
| 1101F |
|
1,501 |
1,494 |
$0.00 |
| 3075F |
|
269 |
244 |
$0.00 |
| 3008F |
|
2,995 |
2,482 |
$0.00 |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
10,898 |
4,532 |
$0.00 |
| 3074F |
|
627 |
520 |
$0.00 |
| 1036F |
|
904 |
899 |
$0.00 |
| 3080F |
|
112 |
98 |
$0.00 |
| 1000F |
|
931 |
926 |
$0.00 |
| 3079F |
|
288 |
256 |
$0.00 |